We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Brian J. Conti is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2008 — 2009 |
Conti, Brian J |
F32Activity Code Description: To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas. |
Mechanisms of Sec61-Mediated Polytopic Protein Integration Into the Er @ Oregon Health and Science University
[unreadable] DESCRIPTION (provided by applicant): The long term goal of the proposed research is to define the precise mechanistic steps employed to ensure the structural maturation of multi-pass membrane proteins as they are synthesized by the ribosome and are integrated into the lipid bilayer. Relevance to disease is especially apparent in cystic fibrosis, which is caused by mutations in the polytopic protein CFTR, leading to its misfolding and, therefore, premature degradation. Intelligent design of disease treatment ultimately relies upon our ability to identify the biosynthetic event gone awry with disease-causing mutant proteins. Using a model polytopic protein, aquaporin 4 (AQP4), the current proposal determines the manner in which transmembrane segments move from the endoplasmic reticulum Sec61 translocon pore into the lipid bilayer, a fundamental phase during the biogenesis of polytopic proteins. Additionally, the functional organization of the translocon during distinct stages of AQP4 biogenesis will be defined using biochemical measures, namely by determining ribosome-translocon complex stability and composition at defined stages. These studies will, thereby, provide valuable information as to how the translocon proceeds step-wise to assemble functional polytopic proteins. PUBLIC HEALTH RELEVANCE One step in the creation of disease treatment is the investigation of how relevant protein mutations lead to the protein's malfunction. Cystic fibrosis is caused by mutations in a membrane bound protein that prevents its structural maturation into a functional protein. This research elucidates mechanisms by which membrane proteins acquire full structural maturation, thereby, providing a framework to examine disease-related mutations in membrane bound proteins. [unreadable] [unreadable] [unreadable]
|
0.937 |